Menu Close

Vacc-iNTS consortium is composed by 12 partners and brings together academic and industry research teams from 4 European countries (Belgium, Italy, Switzerland and United Kingdom), 4 disease endemic countries (Burkina Faso, Ghana, Kenya and Malawi) and 1 non-EU country (New Zealand). The consortium is characterized by a renowned international expertness on vaccine development and characterization, and poverty-related diseases of developing countries.

The Vacc-iNTS project is coordinated by the Sclavo Vaccines Association (, a non-profit organization devoted to support research and development of human vaccines.


Sclavo Vaccines Association (SVA)Italy
GSK Vaccines Institute for Global Health (GVGH)Italy
University of Oxford (UOXF)United Kingdom
Kenya Medical Research Institute (KEMRI)Kenya
University of Cambridge (UCAM)United Kingdom
University of Siena (UNISI)Italy
Institute of Tropical Medicine Antwerp (ITM)Belgium
University of Liverpool (UOL)United Kingdom
University of Otago (UNI OF OTAGO)New Zealand
Université Ouaga I Professeur Joseph Ki-Zerbo (OU)Burkina Faso
Kwame Nkrumah University of Science and Technology Kumasi (KNUST)Ghana
MMGH Consulting GMBH (MMGH)Switzerland

Linked Third Parties

Fondazione Achille Sclavo ONLUSItaly
Glaxosmithkline Biologicals SABelgium
University of MalawiUnited Kingdom